Izuru Ando

587 total citations
9 papers, 485 citations indexed

About

Izuru Ando is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Izuru Ando has authored 9 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Izuru Ando's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and HIV/AIDS drug development and treatment (4 papers). Izuru Ando is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and HIV/AIDS drug development and treatment (4 papers). Izuru Ando collaborates with scholars based in Japan and United States. Izuru Ando's co-authors include Satoru Ikeda, Shintaro Hirashima, Hiromasa Hashimoto, Takayoshi Suzuki, Satoru Noji, Tsuyoshi Adachi, Yoshinori Tsukumo, Kensuke Miyake, Sachiko Akashi and Tetsuya Wakabayashi and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Virology.

In The Last Decade

Izuru Ando

9 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izuru Ando Japan 7 197 159 105 92 85 9 485
Dinesh Manvar United States 16 345 1.8× 95 0.6× 92 0.9× 245 2.7× 75 0.9× 31 722
Chin-Kai Tseng Taiwan 17 75 0.4× 107 0.7× 202 1.9× 213 2.3× 101 1.2× 34 715
Waleed A. Zalloum Jordan 15 252 1.3× 49 0.3× 216 2.1× 281 3.1× 64 0.8× 34 697
Hafiz Muzzammel Rehman Pakistan 13 111 0.6× 33 0.2× 49 0.5× 198 2.2× 53 0.6× 62 480
Judy S. Mathew United States 10 103 0.5× 80 0.5× 206 2.0× 220 2.4× 123 1.4× 13 466
Jiashu Xie United States 17 97 0.5× 62 0.4× 230 2.2× 289 3.1× 120 1.4× 48 658
Sheng Tang China 17 237 1.2× 58 0.4× 71 0.7× 379 4.1× 90 1.1× 43 752
Guoping Peng China 12 40 0.2× 114 0.7× 104 1.0× 112 1.2× 225 2.6× 23 545
Limei Gao China 18 215 1.1× 76 0.5× 69 0.7× 292 3.2× 109 1.3× 49 823

Countries citing papers authored by Izuru Ando

Since Specialization
Citations

This map shows the geographic impact of Izuru Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izuru Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izuru Ando more than expected).

Fields of papers citing papers by Izuru Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izuru Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izuru Ando. The network helps show where Izuru Ando may publish in the future.

Co-authorship network of co-authors of Izuru Ando

This figure shows the co-authorship network connecting the top 25 collaborators of Izuru Ando. A scholar is included among the top collaborators of Izuru Ando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izuru Ando. Izuru Ando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Ogura, Naoki, et al.. (2012). Genotypic and Phenotypic Analyses of Hepatitis C Virus from Patients Treated with JTK-853 in a Three-Day Monotherapy. Antimicrobial Agents and Chemotherapy. 57(1). 436–444. 1 indexed citations
3.
Ando, Izuru, Tsuyoshi Adachi, Naoki Ogura, et al.. (2012). Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrobial Agents and Chemotherapy. 56(8). 4250–4256. 12 indexed citations
4.
Noguchi, Tohru, et al.. (2008). Isolation and gene analysis of interferon α-resistant cell clones of the hepatitis C virus subgenome. Virology. 375(2). 424–432. 8 indexed citations
5.
Hirashima, Shintaro, Takahiro Oka, Kazutaka Ikegashira, et al.. (2007). Further studies on hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors toward improved replicon cell activities: Benzimidazole and structurally related compounds bearing the 2-morpholinophenyl moiety. Bioorganic & Medicinal Chemistry Letters. 17(11). 3181–3186. 30 indexed citations
6.
Suzuki, Takayoshi, Shintaro Hirashima, Kenji Mizutani, et al.. (2006). Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: Identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole. Bioorganic & Medicinal Chemistry Letters. 16(7). 1859–1863. 109 indexed citations
7.
Ikegashira, Kazutaka, Takahiro Oka, Shintaro Hirashima, et al.. (2006). Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors. Journal of Medicinal Chemistry. 49(24). 6950–6953. 85 indexed citations
9.
Ando, Izuru, Yoshinori Tsukumo, Tetsuya Wakabayashi, et al.. (2002). Safflower polysaccharides activate the transcription factor NF-κB via Toll-like receptor 4 and induce cytokine production by macrophages. International Immunopharmacology. 2(8). 1155–1162. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026